Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders.

Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP.

Magnes Res. 2006 Mar;19(1):46-52.

2.

Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism.

Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP.

Magnes Res. 2006 Mar;19(1):53-62.

3.

Magnesium VitB6 intake reduces central nervous system hyperexcitability in children.

Mousain-Bosc M, Roche M, Rapin J, Bali JP.

J Am Coll Nutr. 2004 Oct;23(5):545S-548S.

PMID:
15466962
4.
5.

[Neurological aspect of clinical symptoms, pathophysiology and correction in attention deficit hyperactivity disorder].

Nogovitsina OR, Levitina EV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(2):17-20. Russian.

PMID:
16548369
6.
8.
9.
10.
11.

The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial.

Hirayama S, Terasawa K, Rabeler R, Hirayama T, Inoue T, Tatsumi Y, Purpura M, Jäger R.

J Hum Nutr Diet. 2014 Apr;27 Suppl 2:284-91. doi: 10.1111/jhn.12090. Epub 2013 Mar 17.

12.

Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder?

Kamal M, Bener A, Ehlayel MS.

Atten Defic Hyperact Disord. 2014 Jun;6(2):73-8. doi: 10.1007/s12402-014-0130-5. Epub 2014 Mar 9.

PMID:
24610453
13.

Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder.

O'Brien LM, Holbrook CR, Mervis CB, Klaus CJ, Bruner JL, Raffield TJ, Rutherford J, Mehl RC, Wang M, Tuell A, Hume BC, Gozal D.

Pediatrics. 2003 Mar;111(3):554-63.

PMID:
12612236
14.
15.
16.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
17.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
18.

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.

Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK, Tarazi R, Faraone SV.

Arch Gen Psychiatry. 2002 Jul;59(7):649-56.

PMID:
12090818
20.

Predict attention deficit hyperactivity disorder? Evidence -based medicine.

Bener A, Kamal M.

Glob J Health Sci. 2013 Nov 27;6(2):47-57. doi: 10.5539/gjhs.v6n2p47.

Supplemental Content

Support Center